X
IART icon

Xponance’s Integra LifeSciences IART Stock Holding History

Xponance’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,093
Closed -$287K – 1341
2024
Q1 		$287K Sell
8,093
-55
-0.7% -$2.2K ﹤0.01% 1075
2023
Q4 		$355K Sell
8,148
-367
-4% -$14.4K ﹤0.01% 1027
2023
Q3 		$325K Sell
8,515
-180
-2% -$7.57K ﹤0.01% 1018
2023
Q2 		$358K Sell
8,695
-904
-9% -$43.5K ﹤0.01% 1002
2023
Q1 		$551K Sell
9,599
-32
-0.3% -$1.8K 0.01% 893
2022
Q4 		$540K Buy
9,631
+1,063
+12% +$54.1K 0.01% 872
2022
Q3 		$363K Buy
8,568
+59
+0.7% +$3.02K 0.01% 948
2022
Q2 		$460K Buy
8,509
+548
+7% +$32.9K 0.01% 882
2022
Q1 		$512K Sell
7,961
-184
-2% -$12.1K 0.01% 886
2021
Q4 		$546K Buy
8,145
+4
+0% +$271 0.01% 869
2021
Q3 		$557K Sell
8,141
-178
-2% -$12.6K 0.01% 838
2021
Q2 		$568K Buy
8,319
+875
+12% +$61.9K 0.01% 864
2021
Q1 		$514K Buy
7,444
+57
+0.8% +$3.86K 0.01% 767
2020
Q4 		$480K Sell
7,387
-51
-0.7% -$2.74K 0.01% 764
2020
Q3 		$351K Buy
7,438
+1,069
+17% +$50.9K 0.01% 796
2020
Q2 		$299K Buy
+6,369
New +$313K 0.01% 830

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Xponance's IART Position: Q2 2024 in Review

Xponance sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 8,093 shares — an estimated $287K sold.

Xponance first reported a position in IART in Q2 2020 and held it in 16 quarters. The position peaked at $568K in Q2 2021. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • Xponance reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Xponance sold 8,093 Integra LifeSciences shares in Q2 2024, an estimated $287K.
  • Xponance first reported a position in Integra LifeSciences in Q2 2020 and held it in 16 quarters.
  • Xponance's Integra LifeSciences position peaked at $568K in Q2 2021.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.